Research demonstrates that angiogenesis can be hampered under an environment of inflammation as well as impede the inflammation-induced expression of VEGF in MH7A cell partly through the pathway IL-6/JAK2/STAT3/VEGF, providing new prospects for treating rheumatoid arthritis [148]. The gene discussed is IL6; the disease is rheumatoid arthritis.